1.3304
Finanzdaten der Pacific Biosciences Of California Inc-Aktie (PACB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
16.14%
44.65
|
38.44 | 39.77 | 37.15 | 39.22 |
| Cost Of Revenue |
24.57%
28.08
|
22.54 | 25.08 | 38.52 | 29.17 |
| Gross Profit |
4.18%
16.57
|
15.90 | 14.68 | -1.371 | 10.06 |
|
|
5.45%
57.76
|
54.78 | 59.54 | 427.56 | 163.09 |
| Benefits Costs and Expenses |
11.51%
84.81
|
76.06 | 81.66 | 463.53 | 36.54 |
| Costs And Expenses |
11.51%
84.81
|
76.06 | 81.66 | 463.53 | 36.54 |
| Operating Income/Loss |
5.97%
-41.20
|
-38.88 | -44.85 | -428.93 | -153.03 |
| Income/Loss From Continuing Operations Before Tax |
6.78%
-40.17
|
-37.62 | -41.90 | -426.38 | 2.687 |
| Income Tax Expense/Benefit |
47.26%
0.202
|
0.383 | 0.035 | -0.302 | 0.316 |
| Income/Loss From Continuing Operations After Tax |
6.24%
-40.37
|
-38.00 | -41.93 | -426.07 | 2.371 |
|
|
6.24%
-40.37
|
-38.00 | -41.93 | -426.07 | 2.371 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.78%
0.656
|
300.84 | 300.16 | 296.86 | 2.857 |
| Diluted Average Shares |
99.78%
0.656
|
300.84 | 300.16 | 296.86 | 16.73 |
| Basic Earnings Per Share |
0.00%
-0.13
|
-0.13 | -0.14 | -1.44 | 0.02 |
| Diluted Earnings Per Share |
0.00%
-0.13
|
-0.13 | -0.14 | -1.44 | -0.44 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):